A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-12-1033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Serum Metabolomics as a Novel Diagnostic Approach for Pancreatic Cancer

Metabolomics
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

A Metabolomics-Based Biomarker Signature Discriminates Pancreatic Cancer From Chronic Pancreatitis

Gut
Gastroenterology
2017English

Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection

PLoS ONE
Multidisciplinary
2011English

Metabolomics a Novel Biomarker in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Prospective Metabolomics Study Identifies Potential Novel Blood Metabolites Associated With Pancreatic Cancer Risk

International Journal of Cancer
Cancer ResearchOncology
2018English

Isolated Pancreatic Tuberculosis Mimicking Pancreatic Cancer: A Diagnostic Challenge

Case Reports in Gastrointestinal Medicine
2018English

Pancreatic Cancer: A Multidisciplinary Approach

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2011English

Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) as a Novel Diagnostic Serum Biomarker in Pancreatic Ductal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Pyloric Ligation: A Novel Approach to Reduce Delayed Gastric Emptying in Patients With Unresectable Pancreatic Cancer

Journal of the American College of Surgeons
Surgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy